Abstract
Many marine organisms inherently express the presence and function of a new defence mechanism, termed multixenobiotic resistance mechanism (MXRM) because of its similarity to multidrug resistance (MDR) found in tumor cell lines resistant to chemotherapeutic drugs. However, previously no information was available on a possible induction of the activity of MXRM in organisms living at polluted sites. The purpose of the present study was to demonstrate the inducibility of this defence mechanism in the marine snail Monodonta turbinata, an organism known to inhabit a wide range of environmental conditions existing along a pollution gradient. Specimens of M. turbinata used in the present study were collected from March 1993 through March 1994 near Rovinj, Croatia. The accumulation of generally labelled 3H-vincristine (3H-VCR) in the gills of snails living at an unpolluted site was 67% higher and very sensitive to verapamil, an inhibitor of P-glycoprotein activity in comparison to snails living at a polluted site. The accumulation of vincristine (VCR) in snails from a polluted site was reduced and insensitive to verapamil due to the induced state of P-glycoprotein, as was demonstrated immunochemically by the enhanced concentration of a 140 kDa protein cross-reacting with the polyclonal antibodies raised against mammalian P-glycoprotein. MXRM could be induced in snails from the unpolluted site to the level found in snails living at a polluted site either by transplantation for 3 d to a polluted site, or by exposure for 3 d to sea water polluted with Diesel-2 oil (hydrocarbon concentration equivalent to 50 ppb of Kuwait oil). Discovery of the inducibility of this new defence mechanism in aquatic organisms may have important implications in ecotoxicology, as was demonstrated by a 104% enhanced accumulation of VCR in the presence of the MXRM-inhibitor, the so-called “chemosensitizer”. Besides, a striking difference in the levels of MXRM-elements (the sensitivity of the accumulation rate of xenobiotics to verapamil, immunochemical expression of P-glycoprotein, and the sensitivity of the binding of xenobiotics on membrane vesicles to verapamil) found between specimens living at the polluted and unpolluted sites offers a new molecular biomarker for exposure to pollutants.
Similar content being viewed by others
References
Bradley G, Georges E, Ling V (1990) Sex-dependent and independent expression of the P-glycoprotein isoforms in chinese hamster. J cell Physiol 145: 398–408
Burt RK, Thorgeirsson SS (1988) Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J natn Cancer Inst 80: 1383–1386
Center MS (1985) Mechanisms regulating cell resistance to adriamycin: evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem Pharmac 34: 1471–1476
Chambers TC, Chalikonda I, and Eilon G (1990) Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem biophys Res Commun 169: 253–259
Chan KM, Davies PI, Childs S, Veinot S, Ling V (1992) P-glycoprotein genes in the winter flounder, Pleuronectes americanus: isolation of two types of genomic clones carrying 3′ terminal exons. Biochim biophys Acta 1171: 65–72
Chin KV, Tanaka S, Darlington G, Pastan I, Gottesman MM (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J biol Chem 265: 221–226
Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc natl Acad Sci USA 86: 695–698
Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan IH (1986) Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc natl Acad Sci USA 83: 3847–3852
Endicott JA, Ling V (1989) The biochemistry of P-glycoproteinmediated multidrug resistance. A Rev Biochem 58: 137–171
Fairchild CR, Ivy SP, Rushmore T, Lee G, Koo P, Goldsmith ME, Myers CE, Farber E, Cowan KH (1987) Caercinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc natn Acad Sci USA 84: 7701–7705
Ford JM, Hait WN (1990) Pharmocology of drugs that alter multidrug resistance in cancer. Pharmac Rev 42: 155–199
Gant TW, Silverman JA, Bisgaard HC, Burt RK, Marino PA, Thorgeirsson SS (1991) Regulation of 2-acetylamonofluorene mediated and 3-methylcholanthrene mediated induction of multidrug resistance and cytochrome-P4501A gene family expression in primary hepatocyte cultures and rat liver. Molec. Carcinogen 4: 499–509
Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. A Rev Biochem 62: 385–427
Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Hofsli E, Nissen-Meyer J (1990) Reversal of multidrug resistance by lipophilic drugs. Cancer Res 50: 3997–4002
Holland-Toomey B, Epel D (1993) Multixenobiotic resistance in Urechis embrios: protection from environmental toxins. Biol Bull mar biol Lab, Woods Hole 185: 355–364
Horio M, Gottesman MM, Pastan L (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc natl Acad Sci USA 85: 3580–3584
Huet S, Schott B, Robert J (1992) P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines. Br J Cancer 65: 538–544
Ichikawa M, Yoshimura A, Sumizawa T, Shudo N, Kuwazuru Y, Furukawa T, Akiyama S (1991), Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell. J biol Chem 266: 903–908
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants. Biochem biophys Acta 455: 152–162
Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, NY 221: 1285–1288
Kioka N, Yamano Y, Komano T, Ueda K (1992) Heat shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett 301: 37–40
Kurelec B (1992) The multixenobiotic resistance mechanism in aquatic organisms. CRC critical Rev Toxic 22: 23–43
Kurelec B, Britivié S, Rijavec M, Müller WEG, Zahn RK (1977) Benzo(a)pyrene monooxygenase induction in marine fish — molecular response to oil pollution. Mar Biol 44: 211–216
Kurelec B, Krča S, Pivčević B, Ugarković D, Bachmann M, Imsiecke G, Müller WEG (1992) Expression of P-glycoprotein gene in marine sponges. Identification and characterization of the 125-kDa drug-binding glycoprotein. Carcinogenesis 13: 69–76
Kurelec B, Pivčević B (1989) Distinct glutathione-dependent enzyme activities and a verapamil sensitive binding of xenobiotics in a fresh-water mussel Anodonta cygnea. Biochem biophys Res Commun 164: 934–940
Kurelec B, Pivčević B (1991) Evidence for a multixenobiotic resistance mechanism in the mussel Mytilus galloprovincialis. Aquat Toxic 19: 291–302
Kurelec B, Pivčević B (1992) The multidrug resistance-like mechanism in a marine sponge Tethya aurantium. Mar environ Res 34: 249–253
Kurelec B, Pivčević B, Müller WEG (1995) Determination of pollutants with multixenobiotic resistance inhibiting properties. Mar envirol Res 39: 261–265
Kurelec B, Protić M, Britvić S, Kezić N, Rijavec M, Zahn RK (1981) Toxic effects in fish and mutagenic, capacity of water from the Sava River. Bull envir Contam Toxic 26: 179–187
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature, Lond 227: 680–685
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent J biol Chem 193: 265–275
Ma L, Marquardt D, Takemoto L, Center MS (1991) Analysis of P-glycoprotein phosphorilation in HL60 cells isolated for resistance to vincristine. J biol Chem 266: 5593–5599
Minier C, Akcha F, Galgani F (1993) P-glycoprotein expression in Crassostrea gigas and Mytilus edulis in polluted seawater. Comp Biochem Physiol 106B: 1029–1036
Moore M (1992) Cellular and molecular biology and pathology. In: Natural Environment Research Council Report 1991–1992. Plymouth Marine Laboratory, Plymouth, pp 45–46
Morrow CS, Cowan KH (1988) Mechanisms and clinical significance of multidrug resistance. Oncology 2: 55–66
Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49: 1422–1428
Pierre A, Dunn TA, Kraus-Bertier L, Leonce S, Saint-Dizier D, Regnier G, Dhainaut A, Berlion M, Bizzari J-P, Atassi G (1992) In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. Invest New Drugs 10: 137–148
Roninson IB (1992) The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmac 43: 95–102
Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistance cell lines: increased mdrl expression can precede gene amplification. Science, NY 232: 643–645
Sirotnak FM, Yang C-H, Mines LS, Oribe E, Biedler JL (1986) Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistance Chinese hamster cells selected for resistance to Vinca alkaloids. J cell Physiol 126: 266–274
Speeg KV Jr, deLeon C, McGuire W (1992) Uptake of the noncytotoxic transport probe procainamide in the Chinese hamster ovary model of multidrug resistance. Cancer Res 52: 3539–3546
Stow MW, Warr JR (1993) Reduced influx is a factor in accounting for reduced vincristine accumulation in certain verapamilhypersensitive multidrug-resistant CHO lines. FEBS, 320: 87–91
Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localisation of the multidrugresistance gene product P-glycoprotein in normal human tissues. Proc natn Acad Sci USA 84: 7735–7738
Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, Gottesman MM (1987) Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science, NY 236: 1120–1121
Ueda K, Cornwell MM, Gottesman M, Pastan I, Roninson I, Ling V, Riordan JR (1986) The mdr1 gene, responsible for multidrugresistance, codes for the p-glycoprotein. Biochem biophys Res Comm 141: 956–962
Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethazone, but not progesterone. J biol Chem 267: 24248–24252
Waldmann P, Pivčević B, Mueller WEG, Zahn RK, Kurelec B (1995) Increased genotoxicity of aminoanthracene by modulators of multixenobiotic resistance mechanism: studies with the fresh water clam Corbicula fluminea. Mutation Res 342: 113–123
Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T, Akiyama S (1989) Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264: 16282–16291
Yusa K, Tsuruo T (1989) Reversal mechanism of multidrug resistance by verapamil to P-glycoprotein on specific sites and transport of verapamil outwards across the plasma membrane of K562/ADM cells. Cancer Res 49: 5002–5006
Author information
Authors and Affiliations
Additional information
Communicated by O. Kinne, Oldendorf/Luhe
Rights and permissions
About this article
Cite this article
Kurelec, B., Lucić, D., Pivčević, B. et al. Induction and reversion of multixenobiotic resistance in the marine snail Monodonta turbinata . Marine Biology 123, 305–312 (1995). https://doi.org/10.1007/BF00353622
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00353622